Hathal Haddad, Editorial Board of OncoDaily Medical Journal and Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared American Brachytherapy Society’s post on LinkedIn, adding:
“Excited to share my interview on the official podcast of the American Brachytherapy Society.
We discussed key topics shaping the future of cancer care — prostate cancer, interventional radiotherapy (brachytherapy), and the transformative role of artificial intelligence in radiation oncology.
Honored to contribute to this inspiring conversation highlighting how innovation and precision can improve patient outcomes and redefine modern radiotherapy.”
Quoting American Brachytherapy Society‘s post:
“In our inaugural International Spotlight, Dr. Hathal Haddad of University Hospital Tübingen discusses advances in prostate brachytherapy — from prostate artery embolization (PAE) to AI-assisted workflows.
A leader in interventional radiotherapy, he shares how his team is shaping the future of precision care in Germany and beyond.”
You can also read: Brachytherapy for Prostate Cancer: Types, Success Rate, Side effects And More
